Lowenstein Sandler represented FINTOP Capital as lead investor in the transaction. FINTOP Capital, a venture firm focused on early-stage, B2B fintech companies, led the seed round...
Sola’s Seed Funding Round
Protege’s $10 Million Seed Round
Lowenstein Sandler represented Protege in the transaction. Protege announced its $10 million seed round and the launch of its AI training data platform to help resolve...
Centivo’s $75 Million Equity and Debt Financing
Lowenstein Sandler represented Centivo in the transaction. Centivo, a pioneering healthcare company dedicated to making high-quality healthcare more affordable for employers and their employees, secured $75...
Opkey’s $47 Million Series B Funding Round
Lowenstein Sandler represented PeakSpan Capital in the transaction. Opkey, the Artificial Intelligence (AI) continuous test automation platform for enterprise systems, closed its $47 million Series B...
SOCRadar’s $25.2 Million Series B Funding Round
Lowenstein Sandler represented PeakSpan Capital in the transaction. SOCRadar, a leading provider of enterprise-grade, end-to-end threat intelligence and brand protection, completed its $25.2 million Series B...
Centivo’s Acquisition of Eden Health
Lowenstein Sandler and Lippes Mathias represented Centivo, while Foley & Lardner represented Eden Health in the transaction. Centivo, a pioneering healthcare company built to make quality...
Abre’s $24 Million Series A Investment Round
Lowenstein Sandler represented PeakSpan Capital on the transaction. Abre, K-12’s #1 modern data solution, closed the $24 million Series A round. PeakSpan Capital acted as the...
Goodshuffle Software’s $5 Million Series A Funding Round
Lowenstein Sandler represented FINTOP Capital in the transaction. Goodshuffle, a software company focused on the event rental and production industry, closed a $5 million Series A funding...
Colossyan’s $22 Million Series A Funding Round
Lowenstein Sandler represented Lakestar in the transaction. Colossyan, a London-based AI-text-to-video platform, closed its $22 million Series A funding round. The round saw participation from Lakestar,...
Celldex Therapeutics’ $230.5 Million Common Stock Offering
Lowenstein Sandler advised Celldex Therapeutics, Inc. on the offering, and Wilmer Cutler Pickering Hale and Dorr advised the underwriters. Celldex Therapeutics, Inc. (Nasdaq: CLDX) (“Celldex”) announced the...
Anonybit’s $3 Million Funding Round
Lowenstein represented JAM FINTOP in the transaction. Anonybit, an innovator in decentralized biometric authentication and data protection, closed its $3 million funding round. JAM FINTOP was the lead...
Big Health’s Acquisition of Limbix
Lowenstein Sandler represented Big Health in the transaction. Big Health, the leading provider of non-drug digital treatments for mental health, announced the acquisition of Limbix, creators...